Abilify MyCite (aripiprazole tablets embedded with sensor) / Otsuka 
Welcome,         Profile    Billing    Logout  

2 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Abilify MyCite (aripiprazole tablets embedded with sensor) / Otsuka
2017-004602-17: Digital Medicine System

Not yet recruiting
4
60
Europe
DM-Aripiprazole, DM-Olanzapine, DM- Quetiapine, DM-Risperidone, Tablet, Aripiprazole, Olanzapine, Quetiapine, Risperidone
Otsuka Pharmaceutical, Otsuka Pharmaceutical
Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis, Schizophrenia, Psychiatry and Psychology [F] - Mental Disorders [F03]
 
 
NCT06372210: A Trial to Assess a Wearable Patch's Functioning to Detect Medication Ingestion

Completed
N/A
54
US
Placebo IEM tablet, Abilify MyCite®, OPC-14597 Digital, D-Tect Patch
Otsuka Pharmaceutical Development & Commercialization, Inc.
Mental Disorder, Schizophrenia, Major Depressive Disorder, Bipolar I Disorder
07/23
07/23

Download Options